FDA Approves Roll On Testosterone Axiron

This took a while as of January of 2009 the phase 3 trials were closing on the drug. This was a combined effort of Eli Lilly and Acrux pharma to develop the drug.

Acrux – Roll on Testosterone Lotion Trial

The usual warnings as we see with women’s hormones in this formula, don’t let it touch anyone else, unless your female partner wants a little extra perk. I say this as testosterone is sometime prescribed for women so you can rub up a little now, but you have to get close to the arm pit, as that’s where it goes. BD

INDIANAPOLIS, IN and MELBOURNE, AUSTRALIA (November 23, 2010) /PRNewswire/ — Eli Lilly and Company (NYSE:LLY) and Acrux (ASX: ACR) announced that the U.S. Food and Drug Administration (FDA) has approved Axiron® (testosterone) topical solution CIII for replacement therapy in men for certain conditions associated with a deficiency or absence of testosterone. Safety and efficacy of Axiron in males younger than 18 years of age have not been established.

Axiron is the first testosterone topical solution approved for application via an armpit (underarm) applicator. Other forms of testosterone replacement therapy include: oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections and topical gels applied by the hands.